LBA43 Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study
| Autor: | Notohardjo, J.C.L., Veenstra, S., Koster, B.D., Kandiah, V., van der Velde, S., Francken, A.B., Gooiker, G.A., van den Tol, M.P., Bekkenk, M.W., Hof, K.H. in 't, Straver, M.E., Molenkamp, B.G., Vuylsteke, R.J.C.L.M., Lissenberg-Witte, B.I., Labots, M., Chunduru, S.K., van Akkooi, A.C.J., Van Den Eertwegh, F., de Gruijl, T.D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1410-S1410 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|